|
| | | | | | |
| | | | | | | | | | | |
| | | | | | | | | | |
| | | | | | | | | | | |
| | | | | | | | | | | |
| | | | | | | | | | | | |
| | | | | | | | | | | |
| | |
MOBILE HEALTH: MANAGING THE PROCESS TO REALIZE THE BENEFITS
|
| | | | |
| | | | | | | | | |
| | | | |
| | | | | | | | | | | |
| | |
If you missed our webinar on mobile health device regulation for clinical trials, it’s not too late to hear about the opportunities to manage device validation and the
regulatory process to realize the benefits to your mobile
health-enabled clinical trials. - Understand why there is friction between consumer devices and traditional medical devices relative to development and marketing.
- Understand the nature and scope of changes related to regulation of mHealth devices.
- Understand the somewhat hidden costs to be managed in order to support a successful mHealth device.
A
recording is now available to view online or share with colleagues - learn about the scope of changes in mobile health device regulation and the considerations for validating your device.
|
| | | | | | | | |
| | | | | | | | | | | | |
| | | | | | | | | | | |
| | | | | | | |
William Hanlon, PhD Vice President, Head of Global Regulatory Affairs, Covance |
| | | | | | | | | | | | | |
| | | | | | | | | | | |
| | | | | |
REALIZE THE PROMISE AND POTENTIAL OF MOBILE HEALTH
|
|
| | | | | | | | | | | |
| | | | | | | | | | | |
| | | | | | | | | | | |
| | | | | | | | | | | |
| | | | | | | | |
Scott Thiel, MBA, MT (ASCP), RAC
Associate Director, Navigant Consulting, Inc. |
| | | | | | | | | | |
| | | | | | | |
| | | | | | | | | | | |
| | | | | | | | | | | |
| | | | | | | | | | | |
| | | | | | | | | | | |
| | | | | | |
|
|
|
|
